Associations between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoprotein

Biochemical Pharmacology

Volumn 63, Issue 4, 2002, Pages 693-696

  Baker, Jason R ^a   Satarug, Soisungwan ^a   Urbenjapol, Supanee ^a   Edwards, Robert J ^b   Williams, David J ^c   Moore, Michael R ^a,c   Reilly, Paul E B ^d  

^a University of Queensland and Queensland Alliance for Environmental Health Sciences   (Australia)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c QUEENSLAND HEALTH   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Blood pressure; Cadmium; Cytochrome P450; Fatty acid; Human autopsy; Hypertension; Vasoactive metabolites

Indexed keywords

APOPROTEIN; ARACHIDONIC ACID; CADMIUM; CYTOCHROME P450; CYTOCHROME P450 4A11; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BLOOD PRESSURE REGULATION; CAUCASIAN; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; LIPOGENESIS; LIVER LEVEL; MALE; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TISSUE LEVEL; WESTERN BLOTTING; WORK ENVIRONMENT;

ADOLESCENT; ADULT; ALKANE 1-MONOOXYGENASE; CADMIUM; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; IMMUNOCHEMISTRY; KIDNEY; LIVER; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; SMOKING;

EID: 0037085045     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00905-4     Document Type: Article

References (13)

1. Safe levels of cadmium intake to prevent renal toxicity in human subjects
2. Cadmium levels in the lung, liver, kidney cortex and urine samples from Australians without occupational exposure to metals
3. 20-HETE and the kidney: Resolution of old problems and new beginnings
4. Formation of 20-hydroxyecosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: Role of CYP4F2 and CYP4A11
5. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in postmortem liver and kidney cortex samples
6. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans
7. Influence of clinicopathological variables on CYP protein expression in human liver
8. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-ecosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11
9. Cadmium sensitivity differences between liver microsomal drug metabolizing enzymes systems of guinea pig and rat
10. Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats
11. Production of arterial hypertension by cadmium in the dog
12. A 9-year chronic toxicity study of cadmium in monkeys II. Effects of dietary cadmium on circulatory function, plasma cholesstrol and triglyceride
13. Molecular genetics of human blood pressure variation